NewsRoom Articles - Page 54 of 207

ThursdaySep 21, 2023 12:14 pm

Five Ways to Prep Your eCommerce Site for Success

E-commerce accounted for close to 19% of global retail sales in 2022 and was projected to reach a valuation of $5.5 trillion in sales by the end of the year. With tens of millions of e-commerce businesses competing to attract the billions of customers who purchase products online every year, you will need an inspired strategy to stand out from the pack and build an identifiable brand. Lessons learned from this year should inform your decision-making process as you move into 2024. Review data from this year’s campaigns and reports to see if you can glean any insights or spot…

WednesdaySep 20, 2023 12:06 pm

Nottingham University Researchers Find Way to Make Brain Cancer Cells Self-Destruct

Nottingham University researchers have devised a novel means of treating brain cancer that could signal a “quantum leap” in brain-tumor treatments moving forward. A multidisciplinary research team created a new way of targeting and eliminating cancer cells in typically hard-to-treat types of brain tumors that cause cancer cells to essentially self-destruct. This technique involves leveraging bio-nanoantenna, extremely tiny gold particles (nanoparticles) coated with redox active molecules that are specialized to bring about programmed cell death (apoptosis). Upon electrical stimulation, bio-nanoantenna can induce the self-destruction of brain tumor cells, giving physicians a potential treatment option with much higher chances of better…

WednesdaySep 20, 2023 11:15 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources

California-based cancer fighter Renovaro BioSciences is turning the power of its immune system-promoting technology to the fight against pancreatic cancer and other illnesses that tend to leave patients with a short life expectancy once they are diagnosed Renovaro recently announced a binding, exclusive letter of intent (“LOI”) to add GEDI Cube’s artificial intelligence (“AI”) data mining technology to its fight against such cancers GEDI Cube is strengthening its platform’s potential by joining with the NVIDIA Inception program, which nurtures start-ups by providing access to cutting-edge technology, technical resources, and venture capitalists The companies hope to detect pancreatic tumors at early…

WednesdaySep 20, 2023 9:00 am

Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology

U.S.-based generic drug developer SOHM is working to build its product pipeline through registration for distribution in several states and the planned establishment of its own product manufacturing plant in Southern California SOHM is also focused on developing a regenerative medicine portfolio, having issued an LOI recently in its bid to acquire the gene editing technology ABBIE from CGA Intellectual Holdings Inc. ABBIE is a synthetic enzyme technology that includes a DNA binding solution and a DNA integration solution for introducing a functionally edited genome into an “enhanced” cell that could then be introduced into a patient’s body to repair…

TuesdaySep 19, 2023 1:48 pm

Study Shows Climate Change Impacts Infectious Disease Risks

European researchers have published a study associating climate change with the prevalence of infectious disease transmission. The continent-wide study analyzed the prevalence of viruses, bacteria and protozoans that have the potential to infect humans, domestic animals and bats in various climates. The researchers found that rainfall and temperature could affect the prevalence of several potentially pathogenic microorganisms. They investigated more than 75 microbes from an estimated 40 bat and 400 bird species across the European continent and compared their prevalence to different climatic conditions. Increased temperatures and extreme weather events often come to mind when most people think about the…

MondaySep 18, 2023 11:48 am

UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors

New research from the University of Illinois suggests that scientists can leverage the immune system to combat more types of cancer than previous research indicated. A recent study analyzing the effectiveness of treatments that use chimeric antigen receptor T cells to fight cancer cells found that cancer therapies that involve modifying CAR-T cells to improve their anticancer capabilities may also be effective at fighting solid tumors. Past research and plenty of real-world evidence have consistently shown that cancers without solid tumors such as lymphoma and leukemia can be treated through immunotherapies. However, this treatment exhibited barely any effectiveness against cancers…

FridaySep 15, 2023 2:20 pm

Five Considerations When Taking eCommerce Brands Global

For any new company looking to succeed in this age of virtual trade, finding ways to stand out from the rest of the pack will be integral to building a successful brand, especially on the global stage. Adapting your branding to unique audiences should be your first consideration when launching products in foreign markets. This may include researching local cultures and understanding the language and any symbolism locals may place with certain names, packaging or colors. American beauty product and skincare company Estée Lauder learned this lesson when it launched a project in Germany without realizing that the product’s name…

ThursdaySep 14, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) to Discuss Its Cellular Therapy Programs, Clinical Trial Progress at the 25th Annual H.C. Wainwright Global Investment Conference

Longeveron management will present at the 25th Annual H.C. Wainwright Global Investment Conference scheduled for September 11-13, 2023, in New York Wa’el Hashad, the company’s CEO, will discuss Longeveron’s cellular therapy programs in a pre-recorded presentation. Both he and Lisa Locklear, EVP & Chief Financial Officer, will be at the conference to discuss the company’s investment strategies and clinical trial progress The company aims to create awareness among scientists and investors of its clinical trial progress, positive clinical results, and cellular therapy programs Longeveron is evaluating its lead investigational product candidate, a cellular product named Lomecel-B(TM), in ongoing clinical trials…

ThursdaySep 14, 2023 9:00 am

Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development

U.S.-based generic drug developer SOHM recently announced the addition of two leading officers — Dr. David Aguilar (Ph.D) as Chief Operating Officer and Dr. Krishna Bhat (MD, Ph.D, FACC) as Chief Medical Advisor The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins SOHM also recently announced an LOI to acquire a stem cell disruptive technology and related patents, which include the potential for someday treating damaged hearts via…

ThursdaySep 14, 2023 9:00 am

Microdevices to Enable Simultaneous Multiple Studies on Potential Brain Cancer Treatments

Brigham and Women’s Hospital scientists have developed a microdevice to help researchers test the effectiveness of glioma treatments. Gliomas are a type of brain tumor that arise from glial cells in the spinal cord and brain before infiltrating surrounding brain cells. Because the proximity of gliomas to healthy brain cells makes them hard to remove via surgery, glioma treatment often involves removing as much of the tumor via surgery before using chemotherapy or radiation therapy to kill off as many of the remaining cancer cells as possible. Furthermore, researchers find it extremely difficult to test the effects of different drug…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Five Ways to Prep Your eCommerce Site for Success

Nottingham University Researchers Find Way to Make Brain Cancer Cells Self-Destruct

Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources

Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology

Study Shows Climate Change Impacts Infectious Disease Risks

UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors

Five Considerations When Taking eCommerce Brands Global

Longeveron Inc. (NASDAQ: LGVN) to Discuss Its Cellular Therapy Programs, Clinical Trial Progress at the 25th Annual H.C. Wainwright Global Investment Conference

Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development

Microdevices to Enable Simultaneous Multiple Studies on Potential Brain Cancer Treatments

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search